BCI
RETA

Brinker Capital Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Brinker Capital Investments’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,682
Closed -$273K – 1696
2023
Q2 		$273K Buy
2,682
+5
+0.2% +$510 ﹤0.01% 1438
2023
Q1 		$243K Buy
+2,677
New +$243K ﹤0.01% 1424